Biocompatible peritoneal dialysis solutions: many questions but few answers

被引：14
|
作者：
Blake, Peter G. [1 ]
Jain, Arsh K. [1 ]
Yohanna, Sechelle [1 ]
机构：
[1] Univ Western Ontario, Div Nephrol, Kidney Clin Res Unit, London, ON, Canada
来源：
KIDNEY INTERNATIONAL | 2013年 / 84卷 / 05期
关键词：
SYSTEMATIC REVIEWS; TRIALS;
D O I：
10.1038/ki.2013.303
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The clinical value of biocompatible peritoneal dialysis solutions is uncertain because of inconsistent findings in randomized controlled trials. A systematic review by Cho et al. examining 20 such trials suggests a beneficial effect on residual renal function. However, the finding is not robust and may relate to decreased ultrafiltration causing hypervolemia. Future prescribing of these biocompatible solutions will probably continue to be driven by opinion, marketing, and cost considerations rather than by evidence-based medicine.
引用
收藏
页码：864 / 866
页数：3
相关论文
共 50 条
12345